Beijing Biostar Pharmaceuticals Co., Ltd.

Related records

Trials (17)

• Clinical Study of UTD1 Injection in Combination With Capecitabine in Patients With Advanced and Metastatic Breast Cancer
• Clinical Study of Utidelone Injection in Patients With Advanced Non-small Cell Lung Cancer（NSCLC）
• Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Colorectal Cancer
• Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid Tumors
• Efficacy and Safety of Utidelone Capsule and Utidelone Injection in Patients With HER-2 Negative Advanced Breast Cancer
• Phase I-II Clinical Trial of Utidelone Capsule in Patients With Advanced Solid Tumors
• Phase II Clinical Study of Utidelone Capsule (UTD2) in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
• PK and Drug Interaction Study of Utidelone Plus Capecitabine in Patients With Advanced Breast Cancer
• Utidelone and Anlotinib in Advanced Recurrent Metastatic Esophageal Cancer
• Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
• Utidelone Capsule Monotherapy for Patients with Advanced Solid Tumors
• Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast Cancer
• Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer
• Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer
• Utidelone Injection Combined with Bevacizumab Injection for Non-small Cell Lung Cancer Patients with Brain Metastases
• Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer
• Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer